New drug AB801 takes first steps against advanced cancers
NCT ID NCT06120075
First seen Nov 01, 2025 · Last updated May 06, 2026 · Updated 27 times
Summary
This study tests a new drug called AB801, alone or with other treatments, in about 91 people with advanced cancers like lung, colon, breast, or ovarian cancer that have not responded to standard therapies. The main goal is to check the drug's safety and find the best dose. This is an early-stage trial, so it focuses on side effects and how the drug moves through the body, not on curing the cancer.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research Site
Denver, Colorado, 80218, United States
-
Research Site
Washington D.C., District of Columbia, 20007, United States
-
Research Site
Atlanta, Georgia, 30322, United States
-
Research Site
Grand Rapids, Michigan, 49546, United States
-
Research Site
New York, New York, 10128, United States
-
Research Site
Philadelphia, Pennsylvania, 19104, United States
-
Research Site
Dallas, Texas, 75230, United States
-
Research Site
San Antonio, Texas, 78229, United States
-
Research Site
West Valley City, Utah, 84119, United States
-
Research Site
Fairfax, Virginia, 22031, United States
Conditions
Explore the condition pages connected to this study.